AzTrials
AzTrials

Nerve Block; Pain MedicationNCT01409460

Obturator Nerve Block With Femoral and Sciatic Block

A study testing Oburator Nerve block in people with Nerve Block; Pain Medication, run by Trinity Health Of New England at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate how many patients require the addition of the obturator nerve block in the recovery room after the total knee surgery. Also to study the efficacy of blocking the obturator nerve in controlling their knee pain. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Nerve Block; Pain Medication
What is being tested?
Oburator Nerve block
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
16 participants
Where
1 siteUnited States
Study dates
Oct 2008to Jul 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • total knee replacement

Who cannot join

  • Hisory of neurologica disease, diabetes, pregnancy, neuropathy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Saint Francis Hospital and Medical Center

    Hartford, Connecticut, 06105

Other trials in United States

About this study

Official title: Is an Obturator Nerve Block Required for Every Patient Having Total Knee Arthroplasty With Femoral and Sciatic Nerve Block?

The purpose of this study is to evaluate how many patients require the addition of the obturator nerve block in the recovery room after the total knee surgery. Also to study the efficacy of blocking the obturator nerve in controlling their knee pain.

Being tested
Oburator Nerve block, Sham Injection in pectineus muscle.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oburator Nerve blockProcedure or surgery

    Use of selective pain block.

  • Sham Injection in pectineus muscle.Procedure or surgery

    Five minutes after the sham block pain was assessed in these patients. If pain score was 5 or greater a true obturator nerve block was performed on these patients.

Study groups in NCT01409460
Study groupRoleWhat they receive
True Obturator Nerve BlockExperimentalNot described
Receives: Procedure: Oburator Nerve block
Sham BlockSham comparatorNot described
Receives: Procedure: Sham Injection in pectineus muscle.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess the use of obturator Nerve block for patients undergoing total knee arthroplasty

    The need for rescue obturator nerve block in total knee arthoplasty patients who have sucessful femoral nerve block and sciatic nerve block in place.

    Measured: 15 minutes in recovery room post operatively

Secondary outcomes (1)
  1. Pain medication use intra-operatively and in the recovery room after surgery. Pain scores in recovery room.

    Measured: During surgery and until discharge from recovery room.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Aug 2011 (estimated)
  2. Study startOct 2008
  3. Primary completionJun 2009
  4. Study completionJul 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01409460
Sponsor's protocol ID
08-10-003
Status last verified
Oct 2008
First submitted
2 Aug 2011
Last updated
4 Aug 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Oburator Nerve block in people with Nerve Block; Pain Medication, run by Trinity Health Of New England at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess the use of obturator Nerve block for patients undergoing total knee arthroplasty (time frame: 15 minutes in recovery room post operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in